PMCTPharmaCountry
    Accueil

Analyse

Analyses approfondies des marchés pharmaceutiques, des chaînes d'approvisionnement, de la technologie et de la réglementation

#2376 ×

Analyse
30 août 2026•1 min de lecture
High Won Exchange Rate Affects Pharma & Bio Companies Differently
While a weak won usually boosts exporters, pharma and biotech firms see mixed effects as foreign revenue growth is offset by rising foreign‑currency costs for raw materials, debt and liabilities.